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Beta-thalassemia comprises the group of hereditary hemoglobinopathy characterized by pathological beta chains structures in hemoglobin leading to variable 
phenotypes from severe anemia to asymptomatic and apparently 
healthy subjects. Poorly managed cases in some developing 
countries manifest with growth retardation, pallor, jaundice, 
lean body, hepato-splenomegaly, leg ulcers, and extramedullary 
hematopoiesis, along with bony affections due to marrow 
expansion. Frequent packed red cell transfusion therapy results 
with iron overload-related complications such as endocrine 
complication (growth retardation, diabetes mellitus, insufficiency 
of the parathyroid, thyroid, etc.), dilated cardiomyopathy, and 
cirrhosis of the liver.
Cardiac failure following iron overload is the chief cause 
of death in children with beta-thalassemia major. Majority of 
the affected children suffer from myocardial fibrosis and the 
accompanying iron overload cardiomyopathy [1,2]. Chelation 
therapy diminishes cardiac iron overload and dwindles the 
rate of mortality in such patients. Cardiac involvement in iron 
overload cases includes chamber dilatation, valvular dysfunction, 
pericarditis, arrhythmias, and muscular hypertrophy resulting in 
cardiac failure [2,3]. Iron stores mainly exist in the body in the 
form of ferritin, a bit of which is secreted into the plasma. With 
no inflammation in place, the concentration of the serum ferritin 
correlates positively with the amount of the iron stores.
Normal serum ferritin concentration varies with age and sex. 
At birth, its high followed by an elevation in an initial couple 
of months of life, and thereafter falls by late infancy [4]. By the 
1st year, concentrations begin to rise again and continue to increase 
henceforth [5]. By adolescence, males have a higher concentration 
than the females, which continues into adulthood. It is also an 
acute-phase protein elevates significantly in numerously different 
other conditions and some studies report its poor correlation with 
myocardial iron load, though has got a linear correlation with 
the hepatic iron stores [6,7]. Still, concentration >2500 ng/mL 
indicates dangerous total body iron content [8]. Such persistently 
elevated serum ferritin levels can assist in predicting a grave risk 
of cardiac involvement [9].
Serum ferritin levels can predictably ascertain cardiac iron 
overload when cardiac magnetic resonance imaging T2* is used 
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as the gold standard [10,11]. Little is known about the natural 
history of iron deposition in the heart. In non-chelated patients 
receiving regular transfusions, cardiomegaly develops by the age 
of 10 years and heart failure by the age of 16 years [12]. Previous 
studies acknowledged that serum ferritin levels were higher 
in beta-thalassemia patients who had received more than 50 
transfusions [11]. The objectives of our study were to assess the 
predictive abilities of some of the clinical attributes of the beta-
thalassemia patients regarding cardiac iron overload to identify 
at-risk patients and hence using the knowledge to sensitize the 
clinician in screening the at-risk patients and hence, reducing the 
morbidity and mortality.
MATERIALS AND METHODS
This current observational analytical cross-sectional study was 
conducted in the Department of Paediatrics, VIMSAR, Burla; a 
tertiary care hospital situated in the Western part of Odisha after 
taking approval from the Institute’s Ethical Committee. In previous 
studies, the correlation factor for ejection fraction (EF) with serum 
ferritin was noted to be r=0.31 and as this is the most recent study 
as well as similar to our present study, we chose this the reference 
for calculating the sample size of our present study. Sample size 
was calculated by regression-correlation coefficient (testing for 
r=0) method with taking the reference coefficient factor as r=0.31, 
and power of the study to be 90% and α=5% and taking two-sided 
significance level, minimum sample size was calculated to be 104 
using n master (v2, BRTC, Bagayam, Vellore).
A total of 115 cases were enrolled in the study as per the 
inclusion criteria which included multi-transfused [13] beta-
thalassemic in the age group of 6–14 years and exclusion criteria 
which were to exclude the patients with any congenital heart 
diseases, rheumatic heart disease or any other structural heart 
defects and the associated comorbidities such as hypertension, 
dyselectrolytemia, hyperthyroidism, and type 1 diabetes mellitus. 
Out of 115 children, parents of 10 children did not give consent; 
so, 105 patients were recruited by simple consecutive sampling.
All the patients were enquired for age, sex, and units of packed 
red blood cells (PRBCs) transfused till date. Serum ferritin 
levels were measured using enzyme-linked fluorescent assay by 
Biomerieux, India, and the values were recorded. Nine of the 
patients were found to be already receiving chelation therapy 
and rest 96 patients were not receiving any chelation therapy at 
the time of recruitment. They were also investigated with two-
dimensional (2D) echocardiography done by the consulting 
cardiologist in the Department of Cardiology, VIMSAR, Burla 
using the Philips hd11 model and the three different parameters, 
namely EF, left ventricular end diastolic diameter (LVEDD), and 
left ventricular end systolic diameter (LVESD) were noted for 
each of the patients and abnormal values were recorded using 
body surface area nomogram [14].
All the data were compiled in Microsoft Excel and statistical 
analysis was done as discussed in the following section. In this 
study, serum ferritin values, units of PRBCs transfused, age, 
and gender were analyzed for association with EF, LVEDD, 
LVESD, individually using correlation-regression statistics to 
establish their predictive role in detecting abnormality in the 
echocardiographic variables through SPSS software version 25.
RESULTS
Out of 105 children, 55 were boys and 50 were girls with a mean age 
of 9.4±3.2 years and a mean serum ferritin level of 3240±1254 ng/
ml and mean hemoglobin levels of 6.1±1.2 g/dl. With the 
regression-correlation statistics as evident from the correlation-
regression graphs, serum ferritin has a strongly negative 
correlation with LVEDD with Pearson’s coefficient (r) being 
–0.511 with p=0.000 (Fig. 1).
Serum ferritin has strongest negative correlation with EF 
(r=–0.604, p=0.000) (Fig. 2).
Serum ferritin has weak positive correlation with LVESD 
(r=0.084, p=0.393) (Fig. 3). Number of PRBCs transfused has 
strongly negative correlation with EF (r=–0.785, p=0.000) 
(Fig. 4), weak negative correlation with LVEDD (r=–0.297, 
p=0.005) (Fig. 4), and weak positive correlation with LVESD 
(r=0.413, p=0.000) (Fig. 5).
The prediction model was further evaluated using 
the logistic regression equations as follows; cardiac iron 
overload=1.324 (age in years) +0.046 (sex of the child) –0.164 
(units of PRBC) +0.003 (serum ferritin in ng/ml) –0.571 
Figure 1: Correlation between left ventricular end-diastolic diameter 
and serum ferritin
Figure 2: Correlation between ejection fraction and serum ferritin
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(LVEDD in mm) +1.150 (LVESD in mm) –0.096 (weight in kg) 
+0.006 (height of the child in cm) –21.467.
The correlation between LVESD and units of PRBC 
transfused is described in Fig. 6. The mentioned model (Table 1) 
is good to fit, as evidenced by Cox and Snell R-Square of 0.747 
and Nagelkerke R-Square=1.000 was obtained. This model fits 
the data aptly as Hosmer–Lemeshow χ2 test (5)=0.000, p=1.000. 
With this model, the probability of correct prediction is 93.7%.
Still, some of the variables were insignificant in detecting 
cardiac iron overload; hence, they were excluded from the 
regression model, and new corrected regression model was 
formulated (Table 2). This new model is good to fit, as 
evidenced by Cox and Snell R-Square of 0.613 and Nagelkerke 
R-Square =0.821 were obtained. This model fits the data aptly 
as the Hosmer–Lemeshow χ2 test (8)=20.542 (8), p=0.905. With 
this model, the probability of correct prediction is 94.3%, which 
was calculated in the new corrected logistic regression equation, 
i.e. cardiac iron overload =1.997 (age in years) –3.119 (sex of the 
child) –0.078 (units of PRBC) +0.003 (serum ferritin in ng/ml) 
–0.149 (LVEDD in mm) –0.235 (weight in kg) –10.928.
p=1/1+e-([1.997 (age in years)–3.119 (sex of the child)–
0.078 (units of PRBC)+0.003 (serum ferritin in ng/ml)–0.149 
(LVEDD in mm)–0.235 (weight in kg)]–10.928), where p is the 
probability of cardiac iron overload in multi-transfused pediatric 
beta-thalassemia. If all the risk factors in the above equation 
Figure 3: Correlation between left ventricular end-systolic diameter 
and serum ferritin
Figure 4: Correlation between ejection fraction and units of packed 
red blood cells transfused
Figure 5: Correlation between left ventricular end diastolic diameter 
and units of packed red blood cells transfused
Figure 6: Correlation between left ventricular end-systolic diameter 
and units of packed red blood cells transfused
Table 1: Regression model for cardiac iron overload
Risk factors Adjusted odds ratio 
(95% CI)
p-value
Age in years 3.760 (0.355–19.789) 0.071
Sex of the child (1) 1.048 (0.020–15.133) 0.082
Units of PRBC received till date 0.849 (0.723–0.996) 0.045*
Serum ferritin in ng/ml 1.003 (1.001–1.006) 0.014*
Left ventricular end-diastolic 
diameter in mm
0.565 (0.351–0.911) 0.019*
Left ventricular end-systolic 
diameter in mm
3.158 (0.388–7.183) 0.836
Weight of the child in kg 0.908 (0.635–1.298) 0.097
Height of the child in cm 1.006 (0.776–1.303) 0.965
Ejection fraction in percentage 0.723 (0.419–1.020) 0.865
*p<0.05 is considered as statistically significant, PRBC: Packed red blood cells
Table 2: Corrected regression model for cardiac iron overload
Risk factors Adjusted odds ratio 
(95% CI)
p-value
Age in years 7.369 (2.358–23.023) 0.001*
Units of PRBC received till date 0.0925 (0.814–1.050) 0.045*
Serum ferritin in ng/ml 1.003 (1.001–1.005) 0.004*
Weight of the child in kg 0.791 (0.620–1.008) 0.019*
Sex of the child (male) 0.044 (0.002–0.909) 0.043*
Left ventricular end-diastolic 
diameter in mm
0.862 (0.666–1.115) 0.047*
*p<0.05 is considered as statistically significant, PRBC: Packed red blood cells
Vol 6 | Issue 7 | July 2019 Indian J Child Health 344
Mishra et al.  Iron overload toxicity in multi-transfused thalassemic children
are present in a particular patient of let say a thalassemic boy 
of 8 years old with weight of 18 kg who has received 50 units 
of PRBC till date with serum ferritin value being 4462 ng/
ml and on 2D echocardiography, LVEDD was found to be 
31 mm, the following results were obtained; p=1/1+e-(1.997 
× 8–3.119 × 1–0.078 × 50+0.003 × 4462–0.149 × 31–0.235 × 
18–10.928)=1/1+e–(2.566)=1/1.0768=92.87%. So it means, this 
patient has that the probability of getting cardiac iron overload is 
92.87% and not getting cardiac iron overload is 7.13%.
DISCUSSION
Iron toxicity induced cardiomyopathy is the most crucial cause of 
mortality in beta-thalassemia major children. Serum ferritin is the 
most commonly used predictor of iron overload in thalassemia 
[15]. The serum ferritin level is a non-specific marker for iron 
overload and may elevate in many clinical conditions, including 
inflammation, liver disease, collagen tissue disease, and 
malignancy [16]. Moreover, a low serum ferritin level does not 
correlate to a decreased risk of iron-induced cardiomyopathy [6]. 
Still, much needs to be addressed as cardiomyopathy related 
deaths are more preventable than combatable.
Very few studies have been undertaken that necessitate a 
primarily preventive approach for morbidity regarding iron 
overload toxicity. In one study, no significant correlation was 
observed between serum ferritin, number of units of transfused 
PRBC or age or gender on any cardiac parameter [17]. In our 
present study, we attempted at establishing some predictors of 
iron overload in the form of cardiomyopathy in beta-thalassemia. 
In the correlation graphs and logistic-regression equations, we 
can infer that serum ferritin has got the best correlation with 
EF which is negative followed by LVEDD which is negative as 
well but no correlation with LVESD. Similarly, number of units 
of PRBC transfused has got the best correlation with EF, which 
is negative, followed by LVESD, which is positive, followed 
by LVEDD, which is weakly negative. Furthermore, in the 
logistic regression table, we noted that age, sex, weight of the 
child, serum ferritin, number of PRBC transfused, and LVEDD 
which is an echocardiographic parameter have the significant 
predictive ability in detecting cardiac iron overload and can be 
used collectively for detection of at-risk patients well before in 
lead time.
Limitation of our study is less sample size, study design and 
could not be generalized as ours is the hospital-based study. Hence, 
in future, a follow-up study is highly awaited for best possible 
evidence in detecting risk factors for cardiac iron overload among 
beta-thalassemic children.
CONCLUSIONS
In beta-thalassemia, cardiac dysfunction assessment through 
echocardiography provides an early window to scrutinize for any 
cardiac iron overload toxicity induced dysfunction. This study 
depicts the significance of serum ferritin, number of units of 
PRBCs transfused, age, weight, gender, and LVEDD as having 
predictive ability. Serum ferritin and number of PRBC transfused 
have the strongest correlation with EF. This knowledge can 
establish a warning bell in scrutinizing at-risk patients for cardiac 
iron overload well before in lead time to reduce associated 
morbidity and mortality.
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